30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Robert Funck

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 88% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Vice President, Controller Abbott Laboratories Jan. 1, 2013 - Jan. 1, 2018
Compliance Officer, Vice President - Chief Ethics Abbott Laboratories Jan. 1, 2009 - Jan. 1, 2013
Robert Funck's trades of Abbott Laboratories's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-04 2024-11-04
PrS Proposed sale
73,977
165.50
US$4,636,070 		73,977 165.50 US$4,636,070
2024-05-14 2024-05-10
S Sale
44,528 -36.9%
350.50
US$3,573,924 		44,528 -36.9% 350.50 US$3,573,924
2024-05-10 2024-05-10
PrS Proposed sale
21,870
187.84
US$867,962 		21,870 187.84 US$867,962
2023-03-02 2023-03-01
S Sale
1,264 -0.6%
100.70
US$127,285 		1,264 -0.6% 100.70 US$127,285
2020-10-28 2020-10-26
S Sale
83,333 -31.4%
108.83
US$9,068,955 		83,333 -31.4% 108.83 US$9,068,955
2020-03-03 2020-03-02
S Sale
1,356 -0.8%
77.89
US$105,619 		1,356 -0.8% 77.89 US$105,619
2019-03-04 2019-03-01
S Sale
1,002 -0.7%
78.00
US$78,156 		1,002 -0.7% 78.00 US$78,156